A feasibility study: Can information collected to classify for mutagenicity be informative in predicting carcinogenicity?

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Regulatory toxicology and pharmacology : RTP

• Publication date

  2015-06-01

• Fields of study

  Biology, Medicine, Computer Science, Environmental Science

• Identifiers
  DOI 10.1016/j.yrtph.2015.03.003PMID 25792138
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Applying Adverse Outcome Pathways (AOPs) to support Integrated Approaches to Testing and Assessment (IATA).

  2014cited by this paper
• Can in vitro mammalian cell genotoxicity test results be used to complement positive results in the Ames test and help predict carcinogenic or in vivo genotoxic activity? I. Reports of individual databases presented at an EURL ECVAM Workshop.

  2014cited by this paper
• This Safety Data Sheet (SDS) complies with the United Nations Globally Harmonized System (GHS) of Classification and Labeling, Second revised Edition.

  2013cited by this paper
• IARC classes 1 and 2 carcinogens are successfully identified by an alternative strategy that detects DNA-reactivity and cell transformation ability of chemicals.

  2013cited by this paper
• Investigating the relationship between in vitro-in vivo genotoxicity: derivation of mechanistic QSAR models for in vivo liver genotoxicity and in vivo bone marrow micronucleus formation which encompass metabolism.

  2012influential reference
• A core in vitro genotoxicity battery comprising the Ames test plus the in vitro micronucleus test is sufficient to detect rodent carcinogens and in vivo genotoxins.

  2011cited by this paper
• Scientific opinion on genotoxicity testing strategies applicable to food and 3 feed safety assessment

  2011cited by this paper
• Adverse outcome pathways: A conceptual framework to support ecotoxicology research and risk assessment

  2010cited by this paper
• Structural analysis and predictive value of the rodent in vivo micronucleus assay results.

  2010cited by this paper
• Proposed Integrated Decision-tree Testing Strategies for Mutagenicity and Carcinogenicity in Relation to the EU REACH Legislation

  2007cited by this paper
• In vitro approaches to develop weight of evidence (WoE) and mode of action (MoA) discussions with positive in vitro genotoxicity results.

  2007cited by this paper
• How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop.

  2007cited by this paper
• Integrated Testing Strategies for Use in the EU REACH System

  2006cited by this paper
• Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles.

  2006cited by this paper
• An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: I. Identification of carcinogens using surrogate endpoints.

  2006cited by this paper
• The comet assay: a method to measure DNA damage in individual cells

  2006cited by this paper
• Comparative overview of current international strategies and guidelines for genetic toxicology testing for regulatory purposes

  2006influential reference
• Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.

  2005cited by this paper
• Detailed review of transgenic rodent mutation assays.

  2005cited by this paper
• The comet assay for DNA damage and repair

  2004cited by this paper
• Genotoxicity risk assessment: a proposed classification strategy.

  2002cited by this paper
• The Ames Salmonella/microsome mutagenicity assay.

  2000cited by this paper
• Recent advances in the protocols of transgenic mouse mutation assays.

  2000cited by this paper
• The mouse lymphoma assay.

  2000cited by this paper
• Identification of rodent carcinogens and noncarcinogens using genetic toxicity tests: premises, promises, and performance.

  1998cited by this paper
• Current status of bioassays in genetic toxicology--the dominant lethal assay. A report of the U.S. Environmental Protection Agency Gene-Tox Program.

  1985cited by this paper
• 22 – THE DOMINANT LETHAL ASSAY IN THE MALE MOUSE

  1984cited by this paper
• Validation and characterization of the L5178Y/TK+/- mouse lymphoma mutagen assay system.

  1979cited by this paper
• Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection.

  1973cited by this paper

• A systematic literature review and weight of evidence evaluation of the genotoxicity potential of atrazine

  2025cites this paper
• Adjuvant Activity and Toxicological Risks of Lipid Nanoparticles Contained in the COVID‑19 “mRNA Vaccines”

  2024cites this paper
• Prioritization of mycotoxins based on mutagenicity and carcinogenicity evaluation using combined in silico QSAR methods.

  2023cites this paper
• A weight of evidence review of the genotoxicity of titanium dioxide (TiO₂).

  2022cites this paper
• Differences between in vitro and in vivo genotoxicity due to metabolism: The role of kinetics

  2022cites this paper
• A framework for chemical safety assessment incorporating new approach methodologies within REACH

  2022cites this paper
• A Comprehensive Weight of Evidence Assessment of Published Acetaminophen Genotoxicity Data: Implications for its Carcinogenic Hazard Potential.

  2021cites this paper
• A Strategy for Structuring and Reporting 2 a Read-Across Prediction of Toxicity

  2019cites this paper
• In vitro DNA/RNA Adductomics to Confirm DNA Damage Caused by Benzo[a]pyrene in the Hep G2 Cell Line

  2019cites this paper
• Navigating through the minefield of read-across tools: A review of in silico tools for grouping.

  2017cites this paper
• Predicting in vitro genotoxicity by mouse lymphoma L5178Y thymidine kinase mutation assay (MLA): Accounting for simulated metabolic activation of chemicals

  2017cites this paper
• Procedure for toxicological predictions based on mechanistic weight of evidences: Application to Ames mutagenicity

  2017cites this paper
• Approaching Chemical Safety Assessment Through Application of Integrated Approaches to Testing and Assessment: Combining Mechanistic Information Derived from Adverse Outcome Pathways and Alternative Methods

  2017cites this paper
• Genotoxicity Expert Panel review: weight of evidence evaluation of the genotoxicity of glyphosate, glyphosate-based formulations, and aminomethylphosphonic acid

  2016influential citation
• Integrated approach to testing and assessment for predicting rodent genotoxic carcinogenicity

  2016cites this paper
• Systematically evaluating read-across prediction and performance using a local validity approach characterized by chemical structure and bioactivity information.

  2016cites this paper
• Current and Future Perspectives on the Development, Evaluation, and Application of in Silico Approaches for Predicting Toxicity.

  2016cites this paper
• A review of the carcinogenic potential of glyphosate by four independent expert panels and comparison to the IARC assessment

  2016cites this paper
• Evaluating the potential carcinogenic hazard of glyphosate

  2016cites this paper
• A strategy for structuring and reporting a read-across prediction of toxicity.

  2015cites this paper
• Building scientific confidence in the development and evaluation of read-across.

  2015cites this paper
• Cancer

  1923cites this paper